Tissue Regenix Group (TRX)

Sector:

Financials

Index:

FTSE AIM All-Share

 32.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 74.00
  • 52 Week Low: 31.00
  • Currency: UK Pounds
  • Shares Issued: 71.40m
  • Volume: 2,608
  • Market Cap: £22.85m
  • RiskGrade: 22
  • Beta: 0.00

Tissue Regenix CEO to take leave of absence due to ill health

By Michele Maatouk

Date: Thursday 06 Dec 2018

LONDON (ShareCast) - (Sharecast News) - The chief executive officer of Tissue Regenix, Steve Couldwell, will be taking a leave of absence from the start of the next year as he undergoes medical treatment.
During his absence, which is expected to span the first quarter, the board has approved interim management changes to ensure the continuity of the group's strategy. Chairman John Samuel will become executive chairman and Gareth Jones, the current chief financial officer, will become chief operating officer.

John Samuel said: "Steve has done an excellent job of establishing a sound business strategy and delivering positive sales momentum. We are confident we will continue to execute against this strategy and on behalf of the board and everyone at Tissue Regenix, I wish Steve a full and speedy recovery."

The AIM-listed medical technology company also gave a one-line update on trading, saying current trading for FY18 remains in line with the board's expectations.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

TRX Market Data

Currency UK Pounds
Share Price 32.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 74.00
52 Week Low 31.00
Volume 2,608
Shares Issued 71.40m
Market Cap £22.85m
Beta 0.00
RiskGrade 22

TRX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.76% below the market average16.76% below the market average16.76% below the market average16.76% below the market average16.76% below the market average
17.17% below the sector average17.17% below the sector average17.17% below the sector average17.17% below the sector average17.17% below the sector average
Price Trend
78.5% below the market average78.5% below the market average78.5% below the market average78.5% below the market average78.5% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Income Not Available
Growth
34.59% above the market average34.59% above the market average34.59% above the market average34.59% above the market average34.59% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average

TRX Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
12:47 1 @ 32.90p
12:45 607 @ 32.90p
09:59 2,000 @ 32.18p

TRX Key Personnel

CEO Daniel Lee
CFO David Cocke

Top of Page